SARLIVIQ Trademark

Trademark Overview

On Tuesday, April 10, 2012, a trademark application was filed for SARLIVIQ with the United States Patent and Trademark Office. The USPTO has given the SARLIVIQ trademark a serial number of 85593816. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 30, 2015. This trademark is owned by Infinity Pharmaceuticals, Inc.. The SARLIVIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of oncologic and fibrotic diseases and disorders
sarliviq

General Information

Serial Number85593816
Word MarkSARLIVIQ
Filing DateTuesday, April 10, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 30, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 4, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of oncologic and fibrotic diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 18, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameInfinity Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameInfinity Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, November 30, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 30, 2015ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 28, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, April 26, 2015EXTENSION 5 GRANTED
Tuesday, April 21, 2015EXTENSION 5 FILED
Tuesday, April 21, 2015TEAS EXTENSION RECEIVED
Thursday, October 16, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 15, 2014EXTENSION 4 GRANTED
Tuesday, October 14, 2014EXTENSION 4 FILED
Tuesday, October 14, 2014TEAS EXTENSION RECEIVED
Tuesday, April 29, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, April 26, 2014EXTENSION 3 GRANTED
Tuesday, April 22, 2014EXTENSION 3 FILED
Tuesday, April 22, 2014TEAS EXTENSION RECEIVED
Friday, November 15, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 14, 2013EXTENSION 2 GRANTED
Monday, October 14, 2013EXTENSION 2 FILED
Wednesday, November 13, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 14, 2013TEAS EXTENSION RECEIVED
Thursday, March 21, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 19, 2013EXTENSION 1 GRANTED
Tuesday, March 19, 2013EXTENSION 1 FILED
Tuesday, March 19, 2013TEAS EXTENSION RECEIVED
Tuesday, October 30, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 4, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 4, 2012PUBLISHED FOR OPPOSITION
Wednesday, August 15, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 24, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 24, 2012ASSIGNED TO EXAMINER
Wednesday, April 18, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, April 13, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

sarliviq diseases disorders fibrotic oncologic preparations treatment pharmaceutical